Arthritis drug shows promise against severe Covid: study

Tofacitinib, taken orally and sold under the brand name Xeljanz among others, was tested in a trial of 289 patients hospitalized with severe Covid across 15 locations in Brazil.

After 28 days, 18.1 percent of the group receiving the tofacitinib progressed to respiratory failure or death, compared to 29 percent in the placebo group.Respiratory failure refers to a patient requiring noninvasive ventilation through an oxygen mask, or being intubated and placed on a mechanical ventilator.

Serious side effects occurred in 14.1 percent in the tofacitinib group and in 12 percent in the placebo group.

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer's rheumatoid arthritis drug shows benefit in COVID-19 pneumoniaPfizer said on Wednesday (Jun 16) its oral rheumatoid arthritis drug Xeljanz reduced death or respiratory failure in hospitalised COVID-19 ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Pfizer's rheumatoid arthritis drug shows benefit in Covid-19 pneumonia
Source: TODAYonline - 🏆 1. / 99 Read more »

19 new COVID-19 community cases in Singapore, including three unlinkedSINGAPORE: Singapore reported 19 new COVID-19 cases in the community as of noon on Wednesday (Jun 16), including three with no links to previous ... 哇，真么多？
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

19 community cases, including 3 unlinked, among 24 new Covid-19 infections in SingaporeSINGAPORE — Singapore reported 19 new Covid-19 community infections on Wednesday (June 16), three of which have not been traced to any previously reported cases.
Source: TODAYonline - 🏆 1. / 99 Read more »

India's famed Taj Mahal re-opens for tourists as Covid-19 curbs ease
Source: TODAYonline - 🏆 1. / 99 Read more »

Sydney records first local Covid-19 case in more than a month
Source: TODAYonline - 🏆 1. / 99 Read more »